Clinical Trial Update: Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitazoxanide plus ribavirin and peginterferon for treatment-naive HIV coinfected subjects with Hepatitis C Genotype 1; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)
• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection, Hepatitis C Infection | Phase 2 | Status: COMPLETED | Results posted: 2011-09-27